CYDY insider transaction filings
CytoDyn Inc. — 24 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-24. Screen CYDY transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CYDY between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — CytoDyn Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-24 | 4 | Urbach Tanya Durkee — Director | Grant/award (A): 574,385 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | SIMES STEPHEN M — Director | Grant/award (A): 574,385 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Ndhlovu Lishomwa C — Director | Grant/award (A): 574,385 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Lalezari Jacob P — Chief Executive Officer | Grant/award (A): 4,874,691 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Dunlap Ryan — Director | Grant/award (A): 574,385 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Brunke Karen J — Director | Grant/award (A): 574,385 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Blok Tyler — Chief Legal Officer | Grant/award (A): 3,249,794 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Hoffman Robert E. — Chief Financial Officer | Grant/award (A): 4,874,691 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Hoffman Robert E. — Chief Financial Officer | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Urbach Tanya Durkee — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | SIMES STEPHEN M — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Ndhlovu Lishomwa C — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Lalezari Jacob P — Chief Executive Officer | Grant/award (A): 3,000,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Dunlap Ryan — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Brunke Karen J — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Blok Tyler — Chief Legal Officer | Grant/award (A): 1,250,000 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Lalezari Jacob P — Chief Executive Officer | Grant/award (A): 3,000,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Migliarese Antonio — CFO | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 1,000,000 (derivative) · Disposition to issuer (D): 630,222 (derivative) · +6 more | EDGAR |
| 2024-01-05 | 4 | Urbach Tanya Durkee — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | SIMES STEPHEN M — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Ndhlovu Lishomwa C — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Dunlap Ryan — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Brunke Karen J — Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Blok Tyler — EVP of Legal Affairs | Disposition to issuer (D): 100,000 (derivative) · Grant/award (A): 100,000 (derivative) · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CytoDyn Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-04-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-03-05 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2025-12-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-21 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-16 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-07-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CYDY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →